We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Reference sheet · Coagulation · CPC catalog code THRO-006
This sequence carries terminal or reporter modifications (NH2), so no molecular formula or weight is published here — the modified mass must come from the lot certificate of analysis. Residue composition and charge describe the peptide backbone only. Composition figures above are derived arithmetically from the published sequence for the unmodified free peptide. Salt forms (commonly trifluoroacetate or acetate), amidation, and other modifications shift the observed mass — always reconcile against the current lot certificate of analysis.
Volumes for a 1 mg vial of Scrambled TRAP Fragment at common working concentrations. Add solvent slowly down the vial wall and swirl — do not vortex or shake.
Reference standards in the Coagulation class are typically shipped as lyophilized powder and stored desiccated at −20 °C protected from light. Once reconstituted in bacteriostatic water or the assay-appropriate buffer, aliquot and store at −80 °C to minimize freeze–thaw cycles. Confirm handling requirements against your institutional biosafety and radiation protocols before use.
Scrambled TRAP Fragment sits within the Coagulation research class (CPC reference THRO-006). Coagulation peptides act either as chromogenic / fluorogenic substrates for thrombin, FXa, FVIIa, plasmin, and related proteases, or as inhibitors and receptor ligands (e.g. PAR-1/4 activators) that dissect specific cascade nodes. Investigators typically incorporate Scrambled TRAP Fragment as a reference standard, tool ligand, or substrate in the assay contexts listed above. Read on kinetic plate readers at 405 nm (pNA) or fluorescence (AMC / MCA) endpoints.
Scrambled TRAP Fragment (CPC catalog code THRO-006) is a synthetic coagulation cascade peptide / substrate in the coagulation category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.
Published and internal research programs use Scrambled TRAP Fragment as a reference standard in coagulation workflows — for example, chromogenic protease-activity assays and par (protease-activated receptor) signaling studies. Human clinical evidence is not established.
No. Scrambled TRAP Fragment is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.
In a coagulation workflow, Scrambled TRAP Fragment is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. Read on kinetic plate readers at 405 nm (pNA) or fluorescence (AMC / MCA) endpoints.
Other reference standards in the same class — commonly cross-referenced during assay design and comparator selection.